AXIS Capital Holdings Limited

AXIS Capital Holdings Limited (AXS) Market Cap

AXIS Capital Holdings Limited has a market capitalization of $7.68B.

Price: $105.32

0.27 (0.26%)

Market Cap: 7.68B

NYSE · time unavailable

CEO: Vincent Christopher Tizzio

Sector: Financial Services

Industry: Insurance - Diversified

IPO Date: 2003-07-01

Website: https://www.axiscapital.com

AXIS Capital Holdings Limited (AXS) - Company Information

Market Cap: 7.68B|Sector: Financial Services

Company Profile

AXIS Capital Holdings Ltd. engages in the provision of various insurance and reinsurance products and services. It operates through the Insurance and Reinsurance segments. The Insurance segment offers property, marine, terrorism, aviation, political risk, professional lines, liability, accident, and health insurance products. The Reinsurance segment offers non-life treaty reinsurance to insurance companies. The company was founded on December 9, 2002, and is headquartered in Pembroke, Bermuda.

Analyst Sentiment

75%
Strong Buy

From 12 Active Polls

1Y Forecast: $125.75

▲ +19.4% Potential Upside

Consensus Target Metrics

Low Bound

$108

Median

$127

High Bound

$142

Average

$126

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$125.75
▲ +19.40% Upside
Low Target
$108.00
3% Risk
Median Target
$126.50
20% Mid
High Target
$142.00
35% Max
Consensus
Buy
15 / 29 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)7,6857,9027,5148,1057,5098,1378,1357,4596,682
Enterprise Value ($M)8,3928,6098,1457,3956,7927,3925,4856,8217,207
Price to Earnings Ratio (P/E)6.595.267.597.186.329.4410.906.469.66
Price/Earnings-to-Growth Ratio (PEG)0.792.950.641.911.512.91
Price to Sales Ratio (P/S)1.134.514.574.674.435.285.544.714.40
Price to Book Ratio (P/B)1.191.221.181.281.181.321.381.221.10
Price to Free Cash Flow Ratio (P/FCF)3.3416.5614.4712.8611.14-4.9226.3220.9811.38
Enterprise Value to Sales (EV/Sales)4.914.964.264.014.803.744.304.74
Enterprise Value to EBITDA (EV/EBITDA)5.7325.4726.2317.7716.9523.8220.5822.9827.92
Debt to Equity Ratio0.480.230.230.020.020.020.020.250.25

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 AXIS CAPITAL HOLDINGS LTD (AXS) — Investment Overview

🧩 Business Model Overview

Axis Capital Holdings Ltd operates as an institutional capital markets platform spanning investment banking and institutional brokerage (sales & trading and related client execution services). The value chain is centered on originating and advising capital-raising and strategic transactions, then monetizing ongoing market activity through trading relationships and distribution.

In practice, the business converts (1) client access—through advisory capacity, industry coverage, and senior relationship coverage—into (2) repeat mandates and (3) execution revenue from active clients who require liquidity, hedging, and portfolio rebalancing. This creates operational overlap: investment banking wins drive trading participation, and trading performance reinforces client retention for future mandates.

💰 Revenue Streams & Monetisation Model

  • Investment banking fees (advisory and underwriting): primarily event-driven revenue tied to issuance and M&A activity; margin profile depends on deal flow, mix, and competitive pricing.
  • Sales & trading / brokerage revenue: more recurring within cycles, influenced by market liquidity, client activity, and pricing/volume in fixed income and equity markets.
  • Financing-related income (where applicable): income linked to client balance sheet usage and product structuring, subject to counterparty and market risk controls.

Key margin drivers typically include operating leverage (fixed cost base vs. trading/fee production), compensation discipline (variable pay alignment to revenue), and the quality of risk management (limiting losses and enabling market-making participation when spreads and volumes are favorable).

🧠 Competitive Advantages & Market Positioning

Axis Capital’s moat is best characterized through regulatory and capital-based barriers plus client relationship stickiness that function like switching costs. Broker-dealer operations require ongoing compliance, risk controls, capital adequacy, technology, and supervision—raising the cost and time for new entrants to replicate the platform. In addition, institutional clients allocate mandates based on credibility, execution reliability, and underwriting/trading performance, which tends to be reinforced over multiple cycles.

  • Regulatory moat & capital intensity: Maintaining licensed brokerage and underwriting capabilities requires robust supervision, reporting, and risk frameworks, supported by meaningful regulatory capital.
  • Credit culture & risk management: Institutional markets performance depends on counterparty discipline, exposure limits, and valuation/risk governance. Losses or adverse outcomes can quickly impair a firm’s ability to win business and sustain market access.
  • Relationship-driven switching costs: On the sell-side, mandate selection and trading counterparties are “proven execution” businesses; incumbency and performance history reduce client willingness to switch.

Competitive benchmarking (primary peers):

  • Stifel Financial: broader U.S. wealth and institutional presence; competes for high-quality client flow and underwriting/execution mandates.
  • Piper Sandler: strong in targeted sectors and institutional brokerage; competes on execution quality and senior coverage.
  • Jefferies: full-service investment banking scale; competes for large mandates and globally integrated client programs.

Positioning contrast: Axis Capital’s competitive emphasis is on earning institutional mandates and execution share through credibility, discipline, and sector/client focus, rather than matching the pure scale of large global investment banks. Against diversified peers, Axis’s differentiation is less about “one-size-fits-all” coverage and more about building repeatable client relationships that translate into both advisory and trading participation.

🚀 Multi-Year Growth Drivers

  • Capital markets depth and issuance cycles: Over a multi-year horizon, global and regional capital needs (equity issuance, refinancing, M&A) expand the addressable opportunity for investment banking and underwriting-adjacent services.
  • Institutional trading and liquidity demands: Portfolio hedging, risk transfer, and structured financing needs support continued demand for sales & trading and execution quality.
  • Share of mandates to proven counterparties: Regulatory and risk lessons from prior market dislocations tend to favor firms with strong governance, operational controls, and established counterparty discipline.
  • Cross-sell between advisory and execution: Advisory mandates often create ongoing execution relationships, increasing lifetime value per client relationship.

Overall, the long-term TAM is tied to the structural role of investment banks and broker-dealers in channeling capital between investors and issuers, with growth driven by both market activity and incremental share capture from firms that can sustain risk-adjusted performance.

⚠ Risk Factors to Monitor

  • Market cyclicality: Revenue mix is exposed to underwriting and trading activity levels; earnings durability depends on maintaining discipline through downcycles.
  • Regulatory and capital requirement changes: Broker-dealer capital, leverage constraints, and supervisory expectations can affect balance sheet capacity and operating flexibility.
  • Counterparty and credit risk: Sales & trading and financing exposures require active credit monitoring; deterioration can compress margins and impair access to funding/liquidity.
  • Concentration risk: Client, sector, and product concentration can amplify volatility if demand shifts or spreads change materially.
  • Operational and legal risks: Compliance failures, market conduct issues, and model/valuation disputes can result in costly remediation and reputational impact.

📊 Valuation & Market View

Equity markets typically value investment banks and broker-dealers using a blend of earnings power and balance-sheet efficiency. Common valuation frameworks include P/B (especially where tangible equity and regulatory capital are central), EV/EBITDA in some comps, and return-based metrics such as ROE and efficiency ratios.

The valuation multiple tends to be most sensitive to:

  • Normalized profitability across cycles (sustainability of revenues and compensation discipline).
  • Balance-sheet utilization consistent with risk limits (ability to generate revenue without increasing tail risk).
  • Quality of earnings (share of stable execution income vs. event-driven fees).
  • Regulatory capital trajectory (capacity to underwrite/trade without constraining operations).

🔍 Investment Takeaway

Axis Capital Holdings Ltd presents an investment thesis built on regulatory-capital barriers, risk and credit culture, and client relationship stickiness that supports repeat business in both advisory and execution. The business is inherently cyclical, but the structural advantage lies in its ability to win and retain institutional counterparties through disciplined market participation and credible governance—factors that often matter most when capital markets activity fluctuates.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for AXS.

globenewswire.com2026-07-29

AXIS Appoints Rahil Jogani as Head of Technology & Artificial Intelligence Strategy

PEMBROKE, Bermuda, July 29, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited (“AXIS Capital,” “AXIS” or the “Company”) (NYSE: AXS) today announced that it has hired Rahil Jogani to the newly created role of Head of Technology & Artificial Intelligence (AI) Strategy. He will be based in the New York office and report to Group Chief Operations Officer Ann Haugh.

marketbeat.com2026-07-29

Axis Capital Q2 Earnings Call Highlights

Axis Capital NYSE: AXS reported second-quarter results marked by higher insurance premiums, continued profitability in its reinsurance business and an increased focus on underwriting discipline as specialty insurance market conditions soften.

seekingalpha.com2026-07-29

AXIS Capital Holdings Limited (AXS) Q2 2026 Earnings Call Transcript

AXIS Capital Holdings Limited (AXS) Q2 2026 Earnings Call Transcript

zacks.com2026-07-29

AXIS Capital Q2 Earnings Miss Estimates on Higher Catastrophe Losses

AXS's Q2 results reflect premium growth, but higher catastrophe losses and weaker investment income weigh on earnings.

zacks.com2026-07-28

Here's What Key Metrics Tell Us About Axis Capital (AXS) Q2 Earnings

The headline numbers for Axis Capital (AXS) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com2026-07-28

Axis Capital (AXS) Misses Q2 Earnings and Revenue Estimates

Axis Capital (AXS) came out with quarterly earnings of $2.84 per share, missing the Zacks Consensus Estimate of $3.23 per share. This compares to earnings of $3.29 per share a year ago.

globenewswire.com2026-07-28

AXIS Capital Reports Second Quarter Net Income Available to Common Shareholders of $251 Million, or $3.38 Per Diluted Common Share and Operating Income of $211 Million, or $2.84 Per Diluted Common Share

For the  second quarter of 2026 , the Company reports: Annualized return on average common equity ("ROACE") of 17.0% and annualized operating ROACE of 14.3% Combined ratio of 93.1% , producing underwriting income of $143 million Book value per diluted common share of $80.67 For the six months ended June 30, 2026 , the Company reports: Net income available to common shareholders of $498 million , or $ 6.67 per diluted common share and operating income of $468 million , or $ 6.26 per diluted common share Annualized return on average common equity ("ROACE") of 16.9% and annualized operating ROACE of 15.9% Combined ratio of 91.5% , producing underwriting income of $330 million Book value per diluted common share of $80.67 , an increase of $3.47 , or 4.5% , compared to December 31, 2025 , and an increase of $10.33 , or 14.7% compared to June 30, 2025 PEMBROKE, Bermuda, July 28, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or "the Company") (NYSE: AXS) today announced financial results for the second quarter ended June 30, 2026. Commenting on the second quarter 2026 financial results, Vince Tizzio, President and CEO of AXIS Capital said: "AXIS continued to generate consistent, profitable growth in the second quarter, amidst an evolving risk landscape impacted by the Middle East conflict and further transitioning market conditions.

defenseworld.net2026-07-26

Bank of Nova Scotia Purchases 72,465 Shares of Axis Capital Holdings Limited $AXS

Bank of Nova Scotia increased its position in Axis Capital Holdings Limited (NYSE: AXS) by 65.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 183,169 shares of the insurance provider's stock after purchasing an additional 72,465 shares during the

zacks.com2026-07-21

Axis Capital (AXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Axis Capital (AXS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com2026-07-16

Will Axis Capital (AXS) Beat Estimates Again in Its Next Earnings Report?

Axis Capital (AXS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

zacks.com2026-07-16

Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance

AXSM advances AXS-12 toward potential approval after the FDA accepts its NDA for cataplexy in narcolepsy and sets a May 2027 decision date.

globenewswire.com2026-07-15

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

FDA sets PDUFA target action date of May 1, 2027 NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for AXS-12 (reboxetine) for the treatment of cataplexy in narcolepsy. The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of May 1, 2027.

globenewswire.com2026-07-06

AXIS Capital to Release Second Quarter Financial Results on July 28, 2026

PEMBROKE, Bermuda, July 06, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) today announced that it expects to release financial results for the second quarter ended June 30, 2026 on Tuesday, July 28, 2026 after the close of the financial markets. Vince Tizzio, President and Chief Executive Officer, and Matthew Kirk, Chief Financial Officer, will host an investor teleconference, including a question and answer period, on Wednesday, July 29, 2026 at 8:30 a.m.

zacks.com2026-06-29

Strength Seen in Axis Capital (AXS): Can Its 3.9% Jump Turn into More Strength?

Axis Capital (AXS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

zacks.com2026-06-26

AXS Outperforms Industry, Trades Near 52-Week High: Time to Exit?

AXIS Capital's specialty insurance strength, premium growth and underwriting profitability support growth, while currency exposure and economic uncertainty remain concerns.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"AXS reported Q1’26 revenue of $1.64B and net income of $254.8M, with EPS of $3.34 (diluted $3.29). On a YoY basis, revenue rose 11.9% (vs. Q1’25), while net income increased 31.3%. QoQ, revenue declined 5.3% (vs. Q4’25) but net income decreased only 12.0%, indicating improved earnings conversion despite a lighter top line. Margins expanded over the full 4-quarter sequence: net profit margin improved to 15.5% in Q1’26 from 13.2% in Q1’25, and operating margin rose to 90.2% from 16.1% (noting significant volatility in reported operating figures across quarters). Operating cash flow was $519.4M, producing positive free cash flow of $519.4M. Shareholder returns were supported by modest price momentum (1y change +7.5%) and a small dividend yield (~0.43%); buybacks continued, with repurchases of $59.5M during the quarter. Balance sheet data are inconsistent (Q1’26 shows zeros for many line items), but equity remains substantial (~$6.4B historically), suggesting resilience. With total shareholder payouts ongoing and earnings growth strong YoY, the setup is constructive, though valuation is likely demanding given mid-single-digit yield and a P/E near ~7.4x (per provided ratios)."

Revenue Growth

Positive

Revenue was $1.64B in Q1’26, up 11.9% YoY but down 5.3% QoQ, indicating growth remains intact though the sequential quarter softened.

Profitability

Good

Net income increased 31.3% YoY and declined 12.0% QoQ, while net margin improved to 15.5% in Q1’26 from 13.2% in Q1’25, suggesting improving profitability over the 4-quarter window.

Cash Flow Quality

Good

Q1’26 operating cash flow of $519.4M matched free cash flow of $519.4M. Dividends paid were $42.7M and buybacks were ongoing (-$59.5M), supporting shareholder return quality.

Leverage & Balance Sheet

Fair

Historical equity has been steady (~$5.9B–$6.4B). However, the Q1’26 balance sheet fields (assets, liabilities, debt) appear as zeros, making leverage assessment for the latest quarter unreliable.

Shareholder Returns

Positive

Total return support from dividends (~0.43% yield) and repurchases, while the stock’s 1y price change is only +7.5% (not >20%), so momentum is moderate.

Analyst Sentiment & Valuation

Neutral

Consensus price target is $123.88 versus current price $102.04, implying upside. Provided P/E is ~7.4x with a modest yield; valuation looks reasonable but not a clear bargain without stronger sequential delivery.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

AXS delivered a strong Q1 2026 with a 89.8% combined ratio and GA ratio of 10.7% (down 120 bps YoY), supported by disciplined underwriting, reserve releases ($18m total; mostly short-tail), and continued premium growth (+11% gross, +9% net). Insurance growth was driven by expanded classes (high single-digit) and ACS, with ~10 points of insurance growth attributed to ACS/innovations, including funds-at-Lloyd’s structured capacity that management views as capital-efficient exposure to niche specialty lines. Management also highlighted property pricing pressure (-13%) and cyber rate decline (-6%), but asserted risk-adjusted returns still clear thresholds, backed by a portfolio mix shift toward short-tail (~60% of premiums; nearly 2/3 short tail in expanded classes). Reinsurance showed active cycle management (writings reduced >$130m/24% in long-tail) and guidance that reinsurance premiums could be down double digits in 2026. Capital allocation remained active: $93m returned with $300m additional buyback authorization approved.

AI IconGrowth Catalysts

  • Insurance gross written premiums up ~20% YoY, supported by expanded business classes contributing high single-digit growth
  • Access Capacity Solutions (ACS) driving growth: 2/3 of ACS booked premiums in short tail and about ~10 percentage points of insurance growth (incl. innovations of ACS)
  • Reinsurance selective growth in short-tail specialty: short-tail share increased from 50% to 61% YoY; credit and surety targeted lines leaned into with strong cedent relationships
  • Positive underwriting momentum in professional lines: transactional liability rates up 4% and encouragement from pockets of commercial D&O/financial institutions
  • Operational leverage from AI/automation: auto ingestion improving time to clear/register/route submissions by >65% and next-gen underwriting reducing quote cycle time by up to 30%

Business Development

  • Ryan Specialty deal referenced as performing within estimations (signed up in 2025); loss picks consistent with expectations
  • Funds at Lloyd’s (FAO) / “struck funds at Lloyd’s” transactions: one-one structured capacity/pro-rata-like deals providing access to niche specialty lines, products and geographies not otherwise accessible
  • Specific classes/capability referenced for ACS growth via third-party capital: wholesale lower middle market, A&H pet insurance, Surety, U.S. marine, specialty E&O, Allied Health
  • Reinsurance vehicle structures used to align interests with distribution partners; primarily employed in premium adequate property classes

AI IconFinancial Highlights

  • Group combined ratio: 89.8% (10.7% GA ratio) with 0.4% improvement YoY
  • Insurance combined ratio: 86.3%, improved 0.4% YoY; underlying insurance loss ratio 53.3% (up 100 bps vs prior quarter, in line with 2026 forecast expectations)
  • G&A ratio: 10.7% vs 11.9% a year ago (down 120 bps) with corporate G&A spend essentially flat YoY; reaffirming 11% G&A target for full-year
  • Cat losses: $48m; cat loss ratio 3.2% (extreme U.S. winter weather and ~1/3 from Middle East conflict)
  • Reserve release: $18m total (insurance $15m, reinsurance $3m), described as predominantly short-tail lines
  • Property pricing down 13% in the quarter; cyber rates down 6% in the quarter; liability rates up 9% in the quarter

AI IconCapital Funding

  • Returned $93m to shareholders in the quarter: $33m dividends and $60m share repurchases
  • 2025 $400m repurchase authorization: $53m remained at quarter-end
  • Board approved additional $300m repurchase authorization during the quarter
  • Operating cash flow: $590m vs $309m a year ago
  • Investment income: $185m with book yield largely flat; unrealized losses from rate/spread fluctuations headwind to book value per share growth

AI IconStrategy & Ops

  • Portfolio remediation largely behind; maintaining an underwriting approach described as deliberate—slow to recognize good news, fast to assimilate adverse
  • Insurance underwriting growth mix shift: short-tail lines now constitute ~60% of overall premiums (and nearly 2/3 of expanded-class business is short tail)
  • Reinsurance cycle management: reduced long-tail writings by >$130m (24%) due to competitive conditions and risk-adjusted returns not meeting expectations
  • Claims/operations AI initiatives: genetic AI functionality to process First Notice of Loss data to improve speed and consistency/accuracy

AI IconMarket Outlook

  • Full-year 2026 G&A ratio target remains 11%
  • Underlying portfolio growth guidance reiterated: low single digits; expanded lines high single digits; ACS to take insurance into double digits
  • Reinsurance outlook: reinsurance premiums could be down double digits in 2026; long-tail cycle management expected to persist
  • Underlying loss ratio guided to be around Q4 expectations/level for 2026 (management said new business should not change overall loss ratio estimate); noted “in insurance ex cat” framing

AI IconRisks & Headwinds

  • Property pricing pressure: down 13% in the quarter (repricing order-of-returns coming down), though management asserts written business still meets risk-adjusted returns
  • Cyber remains competitive: rates down 6% and management maintains a cautious underwriting stance given AI-driven exposure dynamics
  • Geopolitical uncertainty and Middle East exposures: ongoing monitoring due to conflict-related losses (~1/3 of cat losses in the quarter)
  • Public company D&O market flattening: management remains cautious and selectively evaluates opportunities
  • Reinsurance cycle risk: competitive market leading to expectation that 2026 reinsurance premiums could decline double digits

Q&A: Analyst Interest

  • Reserve development: Management said they remain comfortable with loss reserves, emphasizing a deliberate philosophy (slow to recognize good news, quick when concerned). They disclosed Q1 favorable development was $8m on insurance (mostly short-tail) and a few million on reinsurance, with enhanced actuarial/claims tools supporting continued confidence.
  • Funds at Lloyd’s / return & loss-ratio impact: Management described “funds at Lloyd’s” as one-one structured capacity/pro-rata-like deals that were selective, not expected to repeat each quarter, and primarily provide exposure to niche specialty lines. They said these deals meet pricing hurdles and should not change the guided 2026 underlying loss ratio range.
  • Core growth vs ACS and capital allocation: Management reiterated no change to underlying growth (low single digits) and expanded lines (high single digits), while ACS remains on track for double-digit contribution. For buybacks, they stressed opportunistic execution with no run-rate assumption, implying January slowdown did not reflect a constraint on repurchase authorization or growth priorities.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the AXS Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for AXS.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (AXS)

© 2026 Stock Market Info — AXIS Capital Holdings Limited (AXS) Financial Profile